Vitiligo: Symptoms, Causes, and Treatment in the UK

Vitiligo is a chronic skin condition characterised by the loss of pigment, leading to flat, white patches on the skin. In the UK, it affects approximately 1 in 100 people. These patches occur because the melanocytes—the cells responsible for producing skin pigment called melanin—stop functioning or die. While vitiligo can affect any part of the body, it most commonly appears on the face, hands, neck, and skin creases.

According to NHS guidance, vitiligo can develop at any age, though it frequently appears before the age of 20. It is often associated with other autoimmune conditions, such as thyroid problems or type 1 diabetes, suggesting that the immune system mistakenly attacks the pigment-producing cells.

Common Symptoms

The primary symptom is the appearance of symmetrical or asymmetrical white patches. These patches often start as a slightly paler area of skin that gradually turns completely white. The edges may be smooth or irregular, and sometimes they appear inflamed or reddish. It does not usually cause Physical discomfort like itching or soreness.

The Two Main Types of Vitiligo

• Non-segmental vitiligo: This is the most common form (90% of cases). The patches appear on both sides of the body symmetrically. It is often linked to autoimmune issues.
• Segmental vitiligo: This form is less common and usually appears in childhood. The patches affect only one area or one side of the body and do not typically spread in the same way as non-segmental vitiligo.

The exact cause of vitiligo is not fully understood, but modern medical research points towards a combination of genetic and environmental factors. The prevailing theory is that it is an autoimmune condition. This means the body's immune system perceives melanocytes as foreign invaders and destroys them.

Other potential triggers noted in clinical literature include:

• Genetic predisposition: Around 20% of people with vitiligo have a family member with the condition.
• Neurochemicals: Toxic substances released at nerve endings in the skin may damage pigment cells.
• Environmental triggers: Severe sunburn, exposure to certain industrial chemicals, or high levels of emotional stress can trigger the onset of patches in those already predisposed.

While there is no permanent cure for vitiligo, various treatments can help restore skin colour or improve the appearance of the skin. NICE (National Institute for Health and Care Excellence) guidelines suggest that treatment should be tailored to the extent of the condition and the patient's preferences.

• Topical Corticosteroids: High-potency steroid creams are often the first line of treatment. These may stop the spread of patches and, in some cases, restore some colour.
• Calcineurin Inhibitors: Creams like tacrolimus or pimecrolimus are used, particularly for patches on the face or for children, as they do not thin the skin like steroids.
• Phototherapy: Ultraviolet B (UVB) light treatment, administered in a hospital setting, can help stimulate repigmentation.
• Skin Camouflage: Specialist waterproof creams can be colour-matched to your natural skin tone to hide patches.
• Depigmentation: In very extensive cases, a treatment may be recommended to remove the remaining pigment from the rest of the body to create a uniform white appearance.

Because the white patches of vitiligo lack melanin, they have no natural protection against the sun's ultraviolet (UV) rays. This means the skin in these areas will burn much faster than unaffected skin. Severe sunburn can also worsen vitiligo (known as the Koebner phenomenon). British patients are advised to use high-factor sunscreen (SPF 30 or higher) with a 4 or 5-star UVA rating daily, even on cloudy days.

If you notice new white patches appearing on your skin, it is important to seek a professional diagnosis. An online GP can provide a convenient initial assessment. During a video consultation, you can show the GP the affected areas, and they can discuss your medical history to rule out other conditions like fungal infections (pityriasis versicolor) or chemical leukoderma.

Speaking to an online doctor is beneficial because:

• They can provide a private and comfortable environment to discuss any self-esteem concerns.
• They can prescribe initial topical treatments if appropriate.
• They can arrange blood tests to check for associated autoimmune conditions, such as an underactive thyroid.
• If the diagnosis is uncertain or the condition is spreading rapidly, they can provide a referral to a secondary care dermatologist.